Delivery Order SPE2DR25D1017-SPE2DR26F9ALY
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency's Medical Supply Chain on September 26, 2025, for PREVYMIS 480 MG tablets (7-count packaging) valued at $4,719.34. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 20, 2025. The award represents a child contract under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,973.46 by the Defense Logistics Agency on December 17, 2025, for the supply of Prevymis 480 mg tablets in quantities of seven. The contract is classified as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be fulfilled at the vendor's location in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,719.34 by the Defense Logistics Agency on July 31, 2025, for the supply of Prevymis 480 mg tablets in packages of seven units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 21, 2025, and represents performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The award is a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,973.46 to AmerisourceBergen Drug Corp for the supply of Prevymis 480 mg tablets (7-count packages) on December 17, 2025. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion by January 9, 2026, with performance originating from the vendor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating AmerisourceBergen competed...
- The Defense Logistics Agency awarded a $18,877.36 delivery order to AmerisourceBergen Drug Corp for the supply of Prevymis 480 mg tablets (7-count packaging) under a firm fixed price contract. This competitively awarded, non-set-aside delivery order is scheduled for completion by September 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a $4,973.46 delivery order to AmerisourceBergen Drug Corp for the supply of Prevymis 480 mg tablets (7-count units) under a firm fixed-price contract. The award, issued on December 11, 2025, with completion targeted for January 5, 2026, represents a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Prevymis 480 mg tablets (7-count packages) valued at $4,719.34. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 23, 2025, with performance at the contractor's corporate headquarters in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $4,719.34 to AmerisourceBergen Drug Corp for the supply of Prevymis 480 mg tablets (7-count packages) on September 8, 2025. This firm fixed-price delivery order, with an ultimate completion date of September 29, 2025, represents a non-competitive award utilizing AmerisourceBergen's existing contract vehicle. The pharmaceutical distributor will perform this delivery from its corporate office location in Conshohocken, Pennsylvania,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $14,251.32 by the Defense Logistics Agency's Medical Supply Chain on September 19, 2025. The contract, designated as a firm fixed-price delivery order with no set-aside designation, is scheduled for completion by September 22, 2025. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Prevymis 480 mg tablets (seven-count units) with a ceiling value of $9,946.92. This firm fixed price delivery order is expected to be completed by January 12, 2026, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the company's established...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9ALYDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency for $4,973.46 to supply Prevymis 480 mg tablets (7-count packages) with a firm fixed price. The award, issued on November 28, 2025, is scheduled for completion by December 19, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. This delivery order falls within AmerisourceBergen's comprehensive pharmaceutical supply agreement with the Defense Logistics Agency, which enables the company to deliver a broad range of medications and medical supplies to support military healthcare systems globally. The company's federal contract portfolio demonstrates extensive experience fulfilling medical procurement requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. The Prevymis delivery supports the agency's mission to maintain adequate pharmaceutical inventories for military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 11/27/25 |